These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6527361

  • 1. Effects of sulfhydryl reagents on uterine nuclear estrogen receptors labeled by in vitro exchange with [3H]estradiol or [3H]4-hydroxytamoxifen.
    Attardi B.
    J Recept Res; 1984; 4(7):787-800. PubMed ID: 6527361
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B, Happe HK.
    Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA, Lippman ME, Katzenellenbogen BS.
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Estrogen and antiestrogen binding to rat uterine and pituitary estrogen receptor: evidence for at least two physicochemical forms of the estrogen receptor.
    Jasper TW, Ruh MF, Ruh TS.
    J Steroid Biochem; 1985 Nov; 23(5A):537-45. PubMed ID: 4079371
    [Abstract] [Full Text] [Related]

  • 7. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.
    Pavlik EJ, van Nagell JR, Nelson K, Gallion H, Donaldson ES, Kenady DE, Baranowska-Kortylewicz J.
    Endocrinology; 1986 May; 118(5):1924-34. PubMed ID: 2422013
    [Abstract] [Full Text] [Related]

  • 8. Hydrodynamic characterizations of estrogen receptors complexed with [3H]-4-hydroxytamoxifen: evidence in support of contrasting receptor transitions mediated by different ligands.
    Pavlik EJ, Nelson K, van Nagell JR, Donaldson ES, Walden ML, Hanson MB, Gallion H, Flanigan RC, Kenady DE.
    Biochemistry; 1985 Dec 31; 24(27):8101-6. PubMed ID: 4092059
    [Abstract] [Full Text] [Related]

  • 9. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
    Borgna JL, Scali J.
    J Steroid Biochem; 1988 Oct 31; 31(4A):427-36. PubMed ID: 3050278
    [Abstract] [Full Text] [Related]

  • 10. Multiple forms of nuclear estrogen receptor in the immature rat uterus after in vitro exchange with [3H]estradiol or [3H] antiestrogens.
    Attardi B.
    Mol Cell Endocrinol; 1983 Feb 31; 29(2):159-67. PubMed ID: 6832469
    [No Abstract] [Full Text] [Related]

  • 11. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
    Garcia M, Greene G, Rochefort H, Jensen EV.
    Endocrinology; 1982 Apr 31; 110(4):1355-61. PubMed ID: 7060530
    [Abstract] [Full Text] [Related]

  • 12. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS, Miller MA, Eckert RL, Sudo K.
    J Steroid Biochem; 1983 Jul 31; 19(1A):59-68. PubMed ID: 6887873
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen.
    Monsma FJ, Katzenellenbogen BS, Miller MA, Ziegler YS, Katzenellenbogen JA.
    Endocrinology; 1984 Jul 31; 115(1):143-53. PubMed ID: 6734512
    [Abstract] [Full Text] [Related]

  • 14. Unique molecular properties of a urea- and salt-stable DNA-binding estrogen receptor dimer covalently labeled with the antiestrogen [3H]desmethylnafoxidine aziridine. A comparison with the estrogen-receptor complex.
    Hutchens TW, McNaught RW, Yip TT, Suzuki T, Li CM, Besch PK.
    Mol Endocrinol; 1990 Feb 31; 4(2):255-67. PubMed ID: 2330004
    [Abstract] [Full Text] [Related]

  • 15. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
    Dix CJ, Jordan VC.
    Endocrinology; 1980 Dec 31; 107(6):2011-20. PubMed ID: 7191796
    [Abstract] [Full Text] [Related]

  • 16. Binding of estrogen and antiestrogen in uterine cell nuclei: in vivo autoradiographic studies.
    Ennis BW, Stumpf WE.
    J Steroid Biochem; 1988 Oct 31; 31(4A):405-9. PubMed ID: 3172774
    [Abstract] [Full Text] [Related]

  • 17. Acceptor sites on chromatin for receptor bound by estrogen versus antiestrogen in antiestrogen-sensitive and -resistant MCF-7 cells.
    Singh RK, Ruh MF, Butler WB, Ruh TS.
    Endocrinology; 1986 Mar 31; 118(3):1087-95. PubMed ID: 3948766
    [Abstract] [Full Text] [Related]

  • 18. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
    Clark JH, Markaverich B, Upchurch S, Eriksson H, Hardin JW.
    Adv Exp Med Biol; 1979 Mar 31; 117():17-46. PubMed ID: 474276
    [Abstract] [Full Text] [Related]

  • 19. Different interaction of estradiol and antiestrogens with the estrogen receptor of rat uterus.
    Faye JC, Fargin A, Bayard F.
    Mol Cell Endocrinol; 1986 Sep 31; 47(1-2):119-24. PubMed ID: 3743888
    [Abstract] [Full Text] [Related]

  • 20. Antiestrogen(4-hydroxytamoxifen)-charged estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues is not affected by host hormonal status.
    Klinge CM, Knox DT, Bambara RA, Zain S, Hilf R.
    J Steroid Biochem; 1989 Sep 31; 33(3):335-40. PubMed ID: 2779224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.